AIM Vaccine Co., Ltd. (HKG: 6660)
Hong Kong
· Delayed Price · Currency is HKD 5.85
-0.15 (-2.50%)
Jan 3, 2025, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 7.08 billion as of January 3, 2025. Its market cap has decreased by -28.22% in one year.
Market Cap
7.08B
Enterprise Value
8.75B
Revenue
1.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
5.85
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 7.08B, a decrease of -64.85%. That is a compound annual growth rate of -37.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 7.08B | -4.72% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 149.74B |
| Hansoh Pharmaceutical Group Company | 98.87B |
| JD Health International | 84.92B |
| WuXi Biologics | 68.94B |
| Sinopharm Group | 64.91B |
| Innovent Biologics | 58.07B |
| Sino Biopharmaceutical | 55.71B |
| CSPC Pharmaceutical Group | 53.23B |